•
Dec 31, 2012

Ironwood Pharmaceuticals Q4 2012 Earnings Report

Total Revenue
$27M
Previous year: $32.2M
-16.0%
EPS
-$0.41
Previous year: -$0.07
+485.7%
Gross Profit
$26M
Previous year: $32.2M
-19.1%
Cash and Equivalents
$137M
Previous year: $87.3M
+56.6%
Free Cash Flow
-$25.8M
Previous year: -$11.4M
+127.7%
Total Assets
$230M
Previous year: $209M
+10.0%

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals